-
Je něco špatně v tomto záznamu ?
Preliminary evaluation of a new prototype interferon-gamma release assay for the detection of Mycobacterium tuberculosis-specific T-cell responses in patients with tuberculosis
M. Ibrahimová, K. Doležalová, L. Bača, M. Sukholytka, E. Grage-Griebenow, D. Zapf, S. Saschenbrecker, V. Herbst, E. Kopecká, MK. Vašáková
Jazyk angličtina Země Česko
Typ dokumentu časopisecké články, hodnotící studie
- MeSH
- dítě MeSH
- dospělí MeSH
- interferon gama MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- Mycobacterium tuberculosis * imunologie MeSH
- předškolní dítě MeSH
- senioři MeSH
- senzitivita a specificita MeSH
- T-lymfocyty * imunologie MeSH
- test pomocí interferonu gama * metody MeSH
- tuberkulóza * diagnóza imunologie mikrobiologie MeSH
- Check Tag
- dítě MeSH
- dospělí MeSH
- kojenec MeSH
- lidé středního věku MeSH
- lidé MeSH
- mladiství MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- předškolní dítě MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- hodnotící studie MeSH
Screening for tuberculosis infections (TBI) using the tuberculin skin test or interferon-gamma release assays (IGRA) is crucial in controlling the global TB burden. This study evaluates the performance of a new IGRA for the detection of T-cell responses against Mycobacterium tuberculosis. Blood samples from 34 adults with tuberculosis disease (TB) and from 30 children with TB, TBI or without TB were analyzed using the prototype Quan-T-Cell TB (EUROIMMUN). The pediatric samples were additionally measured using the established QuantiFERON-TB Gold Plus assay (Qiagen). Clinical performance and inter-assay concordance were analyzed. The prototype Quan-T-Cell TB yielded positivity rates of 88.2% and 100% in adults with TB and children with TBI, respectively, at a specificity of 93.8%. Comparison between the two IGRAs showed positive, negative and overall agreement rates of 100%, 93.8% and 96.3%, respectively, with a kappa score of 0.924 indicating almost perfect agreement. Our study shows promising results of the new prototype Quan-T-Cell TB, as reflected by high concordance with the final diagnosis in adults and children and performance comparable to that of the QuantiFERON IGRA. In individual cases, the data suggest that the prototype Quan-T-Cell TB may be even more consistent with TBI-related clinical findings. Unlike the QuantiFERON assay, the Quan-T-Cell TB has a predefined borderline range, which is advantageous as it may help to differentiate non-specific variation near the cut-off, and fewer sample tubes are required per analysis. The new Quan-T-Cell TB may therefore be a good alternative to the established QuantiFERON IGRA for TBI screening. Further assay optimization is underway, including evaluation studies based on larger patient and control cohorts.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc25013005
- 003
- CZ-PrNML
- 005
- 20250605092904.0
- 007
- ta
- 008
- 250605s2025 xr f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s12223-025-01252-w $2 doi
- 035 __
- $a (PubMed)40032785
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Ibrahimová, Markéta $u Laboratory of Immunology, Thomayer University Hospital, Prague, Czech Republic $1 https://orcid.org/0009000759714349
- 245 10
- $a Preliminary evaluation of a new prototype interferon-gamma release assay for the detection of Mycobacterium tuberculosis-specific T-cell responses in patients with tuberculosis / $c M. Ibrahimová, K. Doležalová, L. Bača, M. Sukholytka, E. Grage-Griebenow, D. Zapf, S. Saschenbrecker, V. Herbst, E. Kopecká, MK. Vašáková
- 520 9_
- $a Screening for tuberculosis infections (TBI) using the tuberculin skin test or interferon-gamma release assays (IGRA) is crucial in controlling the global TB burden. This study evaluates the performance of a new IGRA for the detection of T-cell responses against Mycobacterium tuberculosis. Blood samples from 34 adults with tuberculosis disease (TB) and from 30 children with TB, TBI or without TB were analyzed using the prototype Quan-T-Cell TB (EUROIMMUN). The pediatric samples were additionally measured using the established QuantiFERON-TB Gold Plus assay (Qiagen). Clinical performance and inter-assay concordance were analyzed. The prototype Quan-T-Cell TB yielded positivity rates of 88.2% and 100% in adults with TB and children with TBI, respectively, at a specificity of 93.8%. Comparison between the two IGRAs showed positive, negative and overall agreement rates of 100%, 93.8% and 96.3%, respectively, with a kappa score of 0.924 indicating almost perfect agreement. Our study shows promising results of the new prototype Quan-T-Cell TB, as reflected by high concordance with the final diagnosis in adults and children and performance comparable to that of the QuantiFERON IGRA. In individual cases, the data suggest that the prototype Quan-T-Cell TB may be even more consistent with TBI-related clinical findings. Unlike the QuantiFERON assay, the Quan-T-Cell TB has a predefined borderline range, which is advantageous as it may help to differentiate non-specific variation near the cut-off, and fewer sample tubes are required per analysis. The new Quan-T-Cell TB may therefore be a good alternative to the established QuantiFERON IGRA for TBI screening. Further assay optimization is underway, including evaluation studies based on larger patient and control cohorts.
- 650 _2
- $a lidé $7 D006801
- 650 12
- $a test pomocí interferonu gama $x metody $7 D059425
- 650 12
- $a Mycobacterium tuberculosis $x imunologie $7 D009169
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a dítě $7 D002648
- 650 12
- $a tuberkulóza $x diagnóza $x imunologie $x mikrobiologie $7 D014376
- 650 12
- $a T-lymfocyty $x imunologie $7 D013601
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a předškolní dítě $7 D002675
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a mladiství $7 D000293
- 650 _2
- $a mladý dospělý $7 D055815
- 650 _2
- $a interferon gama $7 D007371
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a kojenec $7 D007223
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a hodnotící studie $7 D023362
- 700 1_
- $a Doležalová, Karolína $u Department of Pediatrics, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Bača, Luboš $u Department of Pediatrics, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Sukholytka, Mariia $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Grage-Griebenow, Evelin $u Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany
- 700 1_
- $a Zapf, Dorinja $u Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany
- 700 1_
- $a Saschenbrecker, Sandra $u Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany. s.saschenbrecker@euroimmun.de $1 https://orcid.org/000000024769915X
- 700 1_
- $a Herbst, Victor $u Institute for Experimental Immunology, affiliated to EUROIMMUN Medizinische Labordiagnostika AG, Lübeck, Germany
- 700 1_
- $a Kopecká, Emilia $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 700 1_
- $a Vašáková, Martina Koziar $u Department of Respiratory Medicine, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic
- 773 0_
- $w MED00011005 $t Folia microbiologica $x 1874-9356 $g Roč. 70, č. 2 (2025), s. 493-503
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/40032785 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y - $z 0
- 990 __
- $a 20250605 $b ABA008
- 991 __
- $a 20250605092857 $b ABA008
- 999 __
- $a ok $b bmc $g 2333582 $s 1250115
- BAS __
- $a 3
- BAS __
- $a PreBMC-MEDLINE
- BMC __
- $a 2025 $b 70 $c 2 $d 493-503 $e 20250303 $i 1874-9356 $m Folia microbiologica $n Folia Microbiol (Praha) $x MED00011005
- LZP __
- $a Pubmed-20250605